4.7 Article

Antitumor Effect of Iscador on Breast Cancer Cell Lines with Different Metastatic Potential

Related references

Note: Only part of the references are listed.
Article Obstetrics & Gynecology

Cancer genetics and breast cancer

Kathryn J. Huber-Keener

Summary: The risk of developing breast cancer is multifactorial, but family history and genetic mutations are important fixed variables. It is necessary to identify patients at risk for hereditary breast cancer and understand how to manage that risk.

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2022)

Editorial Material Oncology

Cancer cell heterogeneity and plasticity: From molecular understanding to therapeutic targeting

Dean G. Tang et al.

SEMINARS IN CANCER BIOLOGY (2022)

Review Oncology

Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality

Amanda J. Kerr et al.

Summary: Adjuvant and neoadjuvant breast cancer treatments can decrease breast cancer mortality but may increase mortality from other causes. The benefits and risks of different treatment options have been evaluated using high-quality evidence to guide individual treatment decisions.

CANCER TREATMENT REVIEWS (2022)

Review Oncology

Current Treatment and Future Trends of Immunotherapy in Breast Cancer

Mitchell J. Elliott et al.

Summary: Immunotherapy has a significant impact on breast cancer treatment, but is only effective for a select group of patients. Ongoing clinical trials and emerging data will help refine the treatment strategies. This review summarizes the evidence for immune checkpoint blockade in early and metastatic breast cancer and discusses current and potential future biomarkers for therapeutic response.

CURRENT CANCER DRUG TARGETS (2022)

Review Biotechnology & Applied Microbiology

Plants in Anticancer Drug Discovery: From Molecular Mechanism to Chemoprevention

Arif Jamal Siddiqui et al.

Summary: Cancer is a major cause of death worldwide, and the discovery of new anticancer drugs is crucial. Natural products have been recognized as effective agents against various diseases, including cancer. Plants and microbes are potential sources of natural compounds to combat cancer, and research has advanced to a molecular level, leading to the development of potent anticancer drugs. Plants are abundant resources for the development of novel therapeutic agents to manage and prevent different types of cancer. The high toxicity, unfavorable side effects, and drug resistance of some chemotherapy drugs drive the demand for natural compounds as new anticancer drugs. This evidence-based review provides valuable information for scientists involved in the development of natural, safe, effective, and economical therapeutic agents against various cancers, making an important contribution to the field of drug discovery where combination therapy can enhance the efficacy of newly synthesized drugs.

BIOMED RESEARCH INTERNATIONAL (2022)

Article Multidisciplinary Sciences

Viscotoxin and lectin content in foliage and fruit of Viscum album L. on the main host trees of Hyrcanian forests

Sanaz Yousefvand et al.

Summary: This study evaluated the quantity and quality of viscotoxins and total lectins in different parts of mistletoe plants. The results showed that the highest level of viscotoxins was found in the December foliage of mistletoe settled on Carpinus betulus, while the highest content of lectins was found in the December foliage of mistletoe settled on Parrotia persica and Carpinus betulus. The immature green berries contained higher concentrations of viscotoxins and lectins compared to the mature white berries.

SCIENTIFIC REPORTS (2022)

Review Oncology

Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications

Karama Asleh et al.

Summary: As the field of translational 'omics has progressed, refined classifiers at both genomic and proteomic levels have emerged to decipher the heterogeneity of breast cancer in a clinically-applicable way. The integration of 'omics knowledge at the DNA, RNA and protein levels is further expanding biologic understanding of breast cancer and opportunities for customized treatment. Recent advances in omics-based genomics and proteomics diagnostics, single cell analysis approaches, and targeted therapeutics development have provided valuable insights into the molecular subtyping of triple negative breast cancer and potential treatment strategies.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Review Oncology

Developments in the Management of Metastatic HER2-Positive Breast Cancer: A Review

Julie Lebert et al.

Summary: Approximately 20% of breast cancers overexpress HER2, providing a target for various therapies. The use of anti-HER2 drugs has greatly improved prognosis in metastatic breast cancer. Emerging treatments, including small molecule targeted agents and antibody-drug conjugates, have shown benefits in third-line and beyond settings. The management of brain metastases in HER2-positive patients and the role of endocrine-based treatment in hormone receptor-positive disease are areas of ongoing research.

CURRENT ONCOLOGY (2022)

Review Chemistry, Medicinal

Biological activity of mistletoe: in vitro and in vivo studies and mechanisms of action

Anna Szurpnicka et al.

ARCHIVES OF PHARMACAL RESEARCH (2020)

Review Biophysics

Lipid composition of the cancer cell membrane

Wojciech Szlasa et al.

JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2020)

Review Biochemistry & Molecular Biology

Changes in lipids composition and metabolism in colorectal cancer: a review

Alicja Pakiet et al.

LIPIDS IN HEALTH AND DISEASE (2019)

Article Integrative & Complementary Medicine

Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study

Florian Pelzer et al.

JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2018)

Review Biochemistry & Molecular Biology

Perturbing the Dynamics and Organization of Cell Membrane Components: A New Paradigm for Cancer-Targeted Therapies

Nuno Bernardes et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Radiology, Nuclear Medicine & Medical Imaging

Molecular Classification of Breast Cancer

Elena Provenzano et al.

PET CLINICS (2018)

Article Multidisciplinary Sciences

Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells

T. Srdic-Rajic et al.

SCIENTIFIC REPORTS (2017)

Review Integrative & Complementary Medicine

Effective Medicinal Plant in Cancer Treatment, Part 2: Review Study

Wesam Kooti et al.

JOURNAL OF EVIDENCE-BASED INTEGRATIVE MEDICINE (2017)

Review Oncology

Cell membrane modulation as adjuvant in cancer therapy

Sara Zalba et al.

CANCER TREATMENT REVIEWS (2017)

Article Physics, Multidisciplinary

Cell membrane softening in human breast and cervical cancer cells

Chris Haendel et al.

NEW JOURNAL OF PHYSICS (2015)

Review Biochemistry & Molecular Biology

Regulation of the cancer cell membrane lipid composition by NaCHOleate Effects on cell signaling and therapeutical relevance in glioma

Victoria Llado et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2014)

Review Pathology

Molecular classification of breast cancer

Darina Vuong et al.

VIRCHOWS ARCHIV (2014)

Review Biotechnology & Applied Microbiology

Preclinical and Clinical Effects of Mistletoe against Breast Cancer

Mohsen Marvibaigi et al.

BIOMED RESEARCH INTERNATIONAL (2014)

Article Integrative & Complementary Medicine

Fermented Mistletoe Extract as a Multimodal Antitumoral Agent in Gliomas

Oliver Podlech et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2012)

Review Biochemistry & Molecular Biology

Plant lectins: Targeting programmed cell death pathways as antitumor agents

Lei-lei Fu et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)

Article Multidisciplinary Sciences

Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy

Gwendolyn Barcelo-Coblijn et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Food Science & Technology

Ribosome-Inactivating Proteins: From Plant Defense to Tumor Attack

Maddalena de Virgilio et al.

TOXINS (2010)

Article Chemistry, Physical

Measurement and interpretation of electrokinetic phenomena

A. V. Delgado et al.

JOURNAL OF COLLOID AND INTERFACE SCIENCE (2007)

Article Medicine, Research & Experimental

The registry of cytotoxicity: Toxicity testing cultures to predict acute toxicity (LD50) and testing in animals

W Halle

ATLA-ALTERNATIVES TO LABORATORY ANIMALS (2003)

Article Biochemistry & Molecular Biology

Involvement of caspase-3 in apoptosis induced by Viscum album var. coloratum agglutinin in HL-60 cells

SY Lyu et al.

BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2001)